Skip to main content

Table 2 Common mechanisms of resistance to IGF-1R -targeted drugs

From: IGF-1R targeting in cancer – does sub-cellular localization matter?

Mechanisms of resistance to IGF-1R targeted therapy

References

Constitutive activation of downstream signaling PI3K-AKT-mTOR

[85, 140]

Constitutive activation of downstream signaling MAPK cascade

[141]

Absence of IRS-1, IRS-2

[142]

Plasma IGF-1R sequestering of anti-IGF1R antibodies

[143]

InsR signaling compensating for IGF1R inhibition

[144]

InsR-IGF1R hybrid receptors

[28, 145]

Crosstalk with other receptors

[11, 74, 75, 146,147,148,149]